Colgate-Palmolive Company $CL Shares Sold by Bollard Group LLC

Bollard Group LLC reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 14.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 37,753 shares of the company’s stock after selling 6,531 shares during the quarter. Bollard Group LLC’s holdings in Colgate-Palmolive were worth $2,983,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the stock. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Colgate-Palmolive by 1.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 5,460,629 shares of the company’s stock worth $431,499,000 after acquiring an additional 101,658 shares during the last quarter. Atlas Capital Advisors Inc. acquired a new position in shares of Colgate-Palmolive in the 4th quarter worth approximately $376,000. Ally Financial Inc. acquired a new position in shares of Colgate-Palmolive in the 4th quarter worth approximately $1,027,000. Jacobi Capital Management LLC lifted its holdings in shares of Colgate-Palmolive by 5.8% in the 4th quarter. Jacobi Capital Management LLC now owns 10,543 shares of the company’s stock worth $833,000 after acquiring an additional 581 shares during the last quarter. Finally, CreativeOne Wealth LLC lifted its holdings in shares of Colgate-Palmolive by 7.6% in the 4th quarter. CreativeOne Wealth LLC now owns 16,087 shares of the company’s stock worth $1,271,000 after acquiring an additional 1,140 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

Shares of CL opened at $89.40 on Friday. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33. The firm’s 50 day moving average price is $86.85 and its 200 day moving average price is $86.25. The company has a market cap of $71.54 billion, a P/E ratio of 34.79, a PEG ratio of 4.72 and a beta of 0.33. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. During the same period in the prior year, the firm earned $0.91 EPS. The firm’s revenue for the quarter was up 8.4% on a year-over-year basis. On average, research analysts forecast that Colgate-Palmolive Company will post 3.81 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be given a $0.53 dividend. The ex-dividend date of this dividend is Monday, July 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.4%. Colgate-Palmolive’s dividend payout ratio is currently 82.49%.

Wall Street Analyst Weigh In

CL has been the topic of several recent analyst reports. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 8th. Barclays upped their target price on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Tuesday, May 5th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $102.00 target price on shares of Colgate-Palmolive in a research note on Monday, May 4th. Wall Street Zen downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Sunday, March 29th. Finally, UBS Group upped their target price on shares of Colgate-Palmolive from $98.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Twelve analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $95.88.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.